TG Therapeutics | TGTX - Операционный доход





Операционный доход Изменить Дата
AbbVie USD 6.72B 1.99B 2026-06
Alaunos Therapeutics USD -1.01M 175K 2026-03
Amgen USD 4.61B 777M 2026-06
Ardelyx USD -32.79M 37.89M 2026-03
Arrowhead Research USD -170.09M 28.83M 2026-06
Bayer EUR 827M 2.7B 2026-06
Biogen USD -243.8M 758.1M 2026-06
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Curis USD -11.52M 3.64M 2026-03
Gilead Sciences USD 3.85B 1.17B 2026-06
J&J USD 7.48B 860M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Novartis USD 4.75B 515M 2026-06
Novavax USD 20.94M 100.32M 2025-12
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
TG Therapeutics USD 21.67M 13.12M 2026-06
Verastem USD -44.9M 3.42M 2026-03
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06